HaloPolymer: Record-breaking Performance Figures for Sulfur Hexafluoride

Following the results of December 2012, the production index of sulfur hexafluoride (SF6) in the enterprises of HaloPolymer, which is the only sulfur hexafluoride producer in Eastern Europe and ranked to be 6th in the world market of sulfur hexafluoride, was 130 tons. According to Halocarbon, the annual sulfur hexafluoride production volume of approximately 1,500 tons accounts for 9% of the global production.

In the 12 months of 2012, more than 1277.7 tons of SF6 have been produced, 11.5% more than the previous year.

Sulfur hexafluoride is widely used in the electrical engineering industry as an insulator, in electronic and metal industries as a technological process medium, and also used as an insulator in the middle-range high-voltage electrical equipment at power facilities.

HaloPolymer produces the SF6 of 4N purity that is massively applied in most industries. "Part of the sulfur hexafluoride that we manufacture has purity of 5N0 (this gas is used in specifically narrow areas as medicine, laser and pulse technical equipment), however, 4N specification remains in demand the most today by the market", - the CEO of HaloPolymer, ОАО Maxim Doroshkevich provided his comment.

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.